NLM Logo

rituximab-alliinase conjugate MeSH Supplementary Concept Data 2025


MeSH Supplementary
rituximab-alliinase conjugate
Unique ID
C502340
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C502340
Registry Numbers
0
Previous Indexing
*Antibodies, Monoclonal (2005-2010)
Heading Mapped to
*Carbon-Sulfur Lyases
*Rituximab
Frequency
2
Note
alliinase conjugated to the monoclonal antibody rituximab, which recognizes the CD20 antigen, and the resulting conjugate was targeted to CD20+ B chronic lymphocytic leukemia (B-CLL) and other B-cell lymphomas
Source
Mol Cancer Ther 2005 Feb;4(2):325-31
Date of Entry
2005/07/27
Revision Date
2019/11/01
rituximab-alliinase conjugate Preferred
page delivered in 0.004s